Laura Bonmassar
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases.
Journal: Frontiers in immunology
Published: February 04, 2026
Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 28, 2024
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors.
Journal: Pharmacological research
Published: August 19, 2022
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.
Journal: Cancers
Published: May 26, 2022
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab.
Journal: Frontiers in immunology
Published: July 03, 2020
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 27, 2018
Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.
Journal: Oncotarget
Published: August 03, 2017
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase.
Journal: Biochimica et biophysica acta. General subjects
Published: June 23, 2017
Influence of fatty acid synthase inhibitor orlistat on the DNA repair enzyme O6-methylguanine-DNA methyltransferase in human normal or malignant cells in vitro.
Journal: International journal of oncology
Published: March 02, 2015
The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 30, 2013
Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: February 21, 2013
Circulating tumor cells in colorectal cancer patients.
Journal: Cancer treatment reviews
Published: September 08, 2012
Last Updated: 09/26/2026